4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-041034
Chief Commercial Officer sold 17,000 shares at an average $191.69 ($3,258,736)
- Chief Commercial Officer acquired 17,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
CRUTCHFIELD BRADFORD · Chief Commercial Officer
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-14 | Exercise or conversion : show line 1 in the form | +17,000 | $1.16 | $19,720 | 60,262 | D |
| 2021-06-14 | Sale : show line 2 in the form | −916 | $189.03 | $173,147 | 59,346 | D |
| 2021-06-14 | Sale : show line 3 in the form | −3,084 | $190.01 | $585,995 | 56,262 | D |
| 2021-06-14 | Sale : show line 4 in the form | −3,000 | $191.16 | $573,476 | 53,262 | D |
| 2021-06-14 | Sale : show line 5 in the form | −4,500 | $192.12 | $864,535 | 48,762 | D |
| 2021-06-14 | Sale : show line 6 in the form | −5,100 | $192.97 | $984,128 | 43,662 | D |
| 2021-06-14 | Sale : show line 7 in the form | −400 | $193.64 | $77,456 | 43,262 | D |
| Open-market sales · 17,000 sh · avg $191.69 · $3,258,736 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-06-14 | Exercise or conversion : show line 8 in the form Stock Option (right to buy) | −17,000 | $1.16 | 2027-02-03 | 17,000 | 528,000 | D |
Loading xslF345X03/doc4.xml…